General Information of the Compound
| Compound ID |
CP0423769
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
Cyclic Cidofovir
Show/Hide
|
||||||||||||||||||
| Synonyms |
CHPMPC
Cidofovir prodrug, Gilead
Cyclic HPMPC
Cyclic cidofovir
GS-504 analog
GS-930
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C8H12N3O5P
|
||||||||||||||||||
| Molecular Weight |
261.174
|
||||||||||||||||||
| Canonical SMILES |
Nc1ccn(C[C@H]2COP(O)(=O)CO2)c(=O)n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C8H12N3O5P/c9-7-1-2-11(8(12)10-7)3-6-4-16-17(13,14)5-15-6/h1-2,6H,3-5H2,(H,13,14)(H2,9,10,12)/t6-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
YXQUGSXUDFTPLL-LURJTMIESA-N
|
||||||||||||||||||
| CAS |
127757-45-3
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound